Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2012; 18(23): 2914-2928
Published online Jun 21, 2012. doi: 10.3748/wjg.v18.i23.2914
Figure 3
Figure 3 Immunoblotting analyses to validate the differential expression of proteasome subunit α type-1 (A, 0. 53 ± 0.14 vs 1.81 ± 0.53) and potassium channel tetramerisation domain containing protein 12 (B, 1.21 ± 0.20 vs 0.56 ± 0.07) between trinitrobenzene sulfonic acid treated group and saline control group. The relative expression ratio standardized to β-actin. aP < 0.05 vs saline group. TNBS: Trinitrobenzene sulfonic acid; Psma1: Proteasome subunit α type-1; Kctd12: Potassium channel tetramerisation domain containing protein 12.